Building An AM Quality Data Backbone That Makes AI Credible 
Visionstate Announces $750,000 financing to Support International Expansion and Strategic Growth 
Local AI Registry Launches First Public Registry of AI Business Recommendations 
Agereh Technologies to Attend 2026 ACI-NA Annual Conference & Exhibition in Philadelphia 
FlameProxies Launches Residential Proxy Network Across 180 Countries Without Contract Commitments IT Leaders Rely on Weak Security Protocols Despite Extraordinary Increase in Phishing Threats to Remote Workers
Inconsistency Exists Between Increase in Threat Surface and Employee Preparedness BOSTON, July 27, 2021 —…
iOnctura Project Evaluating Novel PI3Kδ-inhibitor IOA-244 in Lymphoma to be Co-funded by Innosuisse
Project to investigate novel combination therapies in lymphoma with IOA-244 IOA-244 Phase 1b clinical development…
Byondis and Glycotope Enter Platform Access Agreement for Discovery and Development of Antibodies Against Novel GlycoTargets
NEWS RELEASE Byondis and Glycotope Enter Platform Access Agreement for Discovery and Development of Antibodies…
Verona Pharma Announces August 2021 Virtual Investor Conference Participation
LONDON and RALEIGH, N.C., July 27, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Artios Announces $153 Million (£110 Million) Series C Financing Led by Omega Funds and TCG X
Funding propels Artios’ ability to progress beyond synthetic lethality and to continue the exploitation of…
MeMed’s COVID-19 Severity Test Receives CE Mark for Predicting Severe Outcomes in COVID-19 Patients
MeMed’s COVID-19 Severity Test Receives CE Mark for Predicting Severe Outcomes in COVID-19 Patients MeMed…
ERYTECH to Participate in the BTIG Virtual Biotechnology Conference
ERYTECH to Participate in the BTIG Virtual Biotechnology Conference Cambridge, MA (U.S.) and Lyon (France),…
Idorsia announces financial results for the first half 2021 – Building momentum towards becoming a fully-fledged biopharmaceutical company
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 27, 2021Idorsia Ltd…
Hyloris to Report 2021 Half-Year Results on 4 August 2021
Liège, Belgium – 27 July 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty…
Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor
Every year, an estimated 15 million babies are born preterm (before 37 completed weeks of…
Candel Therapeutics Announces Pricing of Initial Public Offering
NEEDHAM, Mass., July 26, 2021 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (“Candel”), a late clinical…
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HOUSTON, July 26, 2021 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing…
Coherus BioSciences to Report Second Quarter 2021 Financial Results on August 5th
REDWOOD CITY, Calif., July 26, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS),…
PLx Pharma Inc.’s VAZALORE to Launch in Over 2,400 Rite Aid Stores in August
— ‘Coming Soon’ placeholders for all three SKUs of VAZALORE to be positioned prominently on…
Atreca to Host Webcast Presentation of Initial Clinical Data from Phase 1b Trial of ATRC-101
Conference call and webcast scheduled for Thursday, July 29th at 8:00 a.m. ET SAN CARLOS,…
DBV Technologies to Report First Half 2021 Financial Results and Business Updates on August 2, 2021
Montrouge, France, July 26, 2021 DBV Technologies to Report First Half 2021 Financial Results and…
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
AUSTIN, Texas, July 26, 2021 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical…
Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03
Amendment Extends NDA Acceptance Date PALATINE, Ill., July 26, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals,…
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
-EyeGate signs non-binding letter of intent to acquire Bayon Therapeutics, a private ophthalmic pharmaceutical company…
Get back to school with tech from Verizon
5G phones, accessories and great deals – Verizon has it all for connected learning BASKING…